Human Genome Sciences
| Industry | Healthcare' Pharmaceuticals |
|---|---|
| Founded | 1992 |
| Defunct | 2012 |
| Fate | acquired by GlaxoSmithKline |
| Headquarters | Rockville, Maryland, U.S. |
Key people | H. Thomas Watkins, CEO & Pres |
| Products | Diagnostic Substances |
Number of employees | 1000 |
| Website | www.hgsi.com |
Human Genome Sciences (HGS) was a biopharmaceutical corporation founded in 1992 by Craig Venter, Alan Walton and Wally Steinberg. It uses the human DNA sequence to develop protein and antibody drugs. It had drugs under development to treat such diseases as hepatitis C, systemic lupus erythmatosis, anthrax, and cancer. It collaborated with other biotechnology and pharmaceutical companies for development partnerships and licensing.
On July 16, 2012, HGS agreed to be purchased by GlaxoSmithKline for $3.6 billion.